Cargando…
Predicting the individualized risk of nonadherence to zoledronic acid among osteoporosis patients receiving the first infusion of zoledronic acid: development and validation of new predictive nomograms
INTRODUCTION: Achieving optimal adherence to zoledronic acid (ZOL) among osteoporosis (OP) patients is a challenging task. Here, we aimed to develop and validate a precise and efficient prediction tool for ZOL nonadherence risk in OP patients. METHODS: We prospectively collected and analyzed survey...
Autores principales: | Li, Chong, Lu, Ke, Shi, Qin, Gong, Ya-qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340933/ https://www.ncbi.nlm.nih.gov/pubmed/35924011 http://dx.doi.org/10.1177/20406223221114214 |
Ejemplares similares
-
Zoledronic acid infusion for prevention and treatment of osteoporosis
por: Sunyecz, John A
Publicado: (2010) -
Acute effect of zoledronic acid infusion on atrial fibrillation development in patients with osteoporosis
por: İlgezdi, Zeynep Demet, et al.
Publicado: (2015) -
Acute uveitis following zoledronic acid infusion
por: Rathnam, Krishna Kumar, et al.
Publicado: (2009) -
Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel, Agnès, et al.
Publicado: (2011) -
Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women
por: Chao, Ma, et al.
Publicado: (2013)